PureTech Health plc (PRTC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 01:22PM EST
| Previous Close | 29.97 |
| Open | 31.30 |
| Bid | 12.41 x 1400 |
| Ask | 47.30 x 1400 |
| Day's Range | 31.96 - 32.00 |
| 52 Week Range | 18.15 - 44.74 |
| Volume | |
| Avg. Volume | 2,484 |
| Market Cap | 934.947M |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.11 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 57.00 |
- Business Wire
PureTech to Present at Two Upcoming Investor Conferences
BOSTON, November 17, 2022--PureTech to Present at Two Upcoming Investor Conferences
- Business Wire
PureTech to Present at the Jefferies London Healthcare Conference
BOSTON, November 09, 2022--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that Daphne Zohar, Founder and Chief Executive Officer, and Julie Krop, M.D., Chief Medical Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 3:50pm GMT / 10:50am EST. A webcast of the presen
- Business Wire
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
BOSTON, November 01, 2022--PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
© 2022 Yahoo. All rights reserved.
